Convert an HbA1c result between mmol/mol and %, and see where it sits against the Australian reference bands.
A reminder tool, not a recommendation. The RACGP type 2 diabetes handbook describes HbA1c monitoring every 3–6 months depending on whether levels are stable and whether treatment is changing. Your GP sets the interval that suits you.
Medicare frequency caps are separate from clinical advice. MBS item 66551 (monitoring established diabetes) is payable not more than 4 times in 12 months; MBS item 66841 (diagnosing diabetes in asymptomatic high-risk patients) is payable once in 12 months. These are billing limits, not a testing schedule — items are searchable at MBS Online ↗.
| mmol/mol | % | est. avg glucose | Australian reference point |
|---|---|---|---|
| 31 | 5.0 | 5.4 | Diabetes unlikely |
| 42 | 6.0 | 7.0 | Lower edge of the higher-risk band |
| 46 | 6.4 | 7.5 | Upper edge of the higher-risk band |
| 48 | 6.5 | 7.8 | Diagnostic threshold for diabetes — repeated to confirm |
| 53 | 7.0 | 8.6 | General target for non-pregnant adults with type 2 diabetes |
| 58 | 7.5 | 9.3 | Top of the range RACGP says still reflects a 53 goal, once test variation is allowed for |
| 64 | 8.0 | 10.2 | Above the general target |
| 75 | 9.0 | 11.8 | Above the general target |
| 86 | 10.0 | 13.4 | Above the general target |
Units converted with the NGSP/IFCC master equation: % = (0.09148 × mmol/mol) + 2.152. Estimated average glucose from the ADAG regression (Nathan et al., Diabetes Care 2008): mmol/L = (1.5944 × %) − 2.5944. The % column is rounded to one decimal place for display, but both the converter and this table calculate the estimated average glucose from the unrounded conversion — so recomputing it from the rounded % can land one decimal place out. Reference points from the RACGP Red Book and the RACGP type 2 diabetes handbook.
These two units look almost identical on a pathology report and get mixed up constantly. They are not the same measurement and cannot be compared with each other.
| Blood glucose | HbA1c | |
|---|---|---|
| Unit | mmol/L | mmol/mol (or %) |
| Measures | Glucose in your blood at that moment | Average glucose over roughly 2–3 months |
| Changes | Hour to hour, with meals | Slowly, over weeks to months |
| Diabetes diagnostic threshold | Fasting 7.0 mmol/L or above | 48 mmol/mol (6.5%) or above |
So a fasting glucose of 5.5 mmol/L and an HbA1c of 55 mmol/mol are unrelated numbers that happen to look similar — the first is below the diabetes threshold, the second is above it. The estimated average glucose in the converter above is the bridge between them: it restates HbA1c in the mmol/L units you see on a finger-prick meter. It is a population average, and an individual's real average can sit either side of it. Diagnostic thresholds from the ADS/AACB/RCPA joint guidance ↗.
The most quoted Australian and international figure comes from UKPDS 35, an observational analysis of the UK Prospective Diabetes Study. In people with type 2 diabetes, each 1% lower average HbA1c was associated with:
| Outcome | Lower risk | 95% CI |
|---|---|---|
| Any diabetes-related endpoint | 21% | 17–24% |
| Deaths related to diabetes | 21% | 15–27% |
| Microvascular complications | 37% | 33–41% |
| Myocardial infarction | 14% | 8–21% |
Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–12. These are statistical associations from observational data, not a promise of benefit from any particular treatment, and the study found no glycaemic threshold below which risk stopped falling. What any of this means for you is a conversation for your GP.
For people with diagnosed diabetes, Australian practice groups a set of checks into an annual cycle of care. Not every item applies to everyone, and intervals change with individual risk — the list below is what Diabetes Australia publishes, as a prompt for your next appointment.
| Check | Published interval |
|---|---|
| HbA1c | At least every 6–12 months (RACGP describes 3–6 monthly monitoring; more often again if treatment is changing) |
| Blood pressure | At least every 6 months |
| Kidney health (eGFR and urine albumin) | At least yearly |
| Cholesterol / blood fats | At least yearly |
| Eye test | At least every 2 years, or more often if advised |
| Foot assessment | Yearly if lower risk; every 3–6 months if higher risk |
| Dental check | At least yearly |
Intervals as published by Diabetes Australia — annual cycle of care ↗ and the NDSS cycle of care fact sheet ↗; HbA1c monitoring interval from the RACGP type 2 diabetes handbook ↗. Diabetes is a qualifying condition for a GP Chronic Condition Management Plan, which is how subsidised allied health visits are arranged.
HbA1c (glycated haemoglobin) reflects average blood glucose over roughly the previous 2–3 months. It is used both to diagnose diabetes and to monitor it over time.
Australian laboratories report it in mmol/mol, following IFCC standardised reporting. Older Australian results and most United States material use % (NGSP/DCCT). The two scales describe the same test.
The NGSP master equation converts between them: % = (0.09148 × mmol/mol) + 2.152, which rearranges to mmol/mol = (% − 2.152) ÷ 0.09148.
The RACGP Red Book describes HbA1c 42–46 mmol/mol (6.0–6.4%) as higher risk of developing diabetes, with screening repeated in one year.
An HbA1c of 48 mmol/mol (6.5%) or above is the diagnostic threshold for diabetes, and RACGP advises that a screening result at or above this level is repeated to confirm the diagnosis.
For non-pregnant adults who already have type 2 diabetes, the RACGP general target is 53 mmol/mol (7.0%) or below, individualised to the person. A more stringent target of 48 mmol/mol (6.5%) may suit someone with short diabetes duration, long life expectancy and no significant cardiovascular disease if it can be reached safely without hypoglycaemia; a less stringent target such as 64 mmol/mol (8.0%) may suit someone with a history of severe hypoglycaemia, limited life expectancy or advanced complications.
One thing worth knowing: the American Diabetes Association uses a wider pre-diabetes band of 5.7–6.4%. United States websites and older material may therefore classify the same result differently from an Australian GP.
Not on its own. RACGP guidance is that a screening HbA1c at or above 48 mmol/mol (6.5%) should be repeated to confirm a diagnosis of diabetes.
A single result above the threshold is a reason to go back to your GP, not a diagnosis you can make from a converter. Your GP interprets it alongside your symptoms, your risk factors and your other test results — and HbA1c is not the right test in some situations (see below).
HbA1c can be misleading in:
In these situations your GP uses glucose-based tests or interprets HbA1c with caution. If any apply to you, the conversion above is still arithmetically correct, but the underlying result may not mean what it usually means.
The RACGP type 2 diabetes handbook describes HbA1c monitoring every 3 to 6 months, depending on whether glucose levels are stable and whether treatment is changing.
Medicare frequency caps are a separate thing from clinical advice. MBS item 66551, for monitoring established diabetes, is payable not more than 4 times in 12 months. MBS item 66841, for diagnosing diabetes in asymptomatic high-risk patients, is payable once in 12 months.
Those are billing limits, not a recommended testing schedule. A test can be clinically appropriate and still fall outside a rebate, and your GP decides the interval that suits you.
✅ Got your number? Watch the trend, not the one-off. The Blood Sugar Log keeps your readings in one printable place, so your GP reads a pattern instead of a single result.
Your GP or healthcare provider knows your history and circumstances. Always follow their personalised advice over general information, including anything on this page.